Laparoscopic surgery for early cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies how well a less invasive laparoscopic surgery works for women with early-stage cervical cancer. If you have a small tumor and need a hysterectomy, this may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a common type of cervical cancer (squamous cell, adenocarcinoma, or adenosquamous).
- Your cancer is early stage (IA2, IB1, or IB2) and the tumor is smaller than 4 cm.
- You are scheduled for a radical or simple hysterectomy, based on your tumor size and depth.
- You are well enough for surgery (ECOG performance status 0 or 1) and have had a preoperative MRI.
- You are 18 or older, not pregnant, and have no other cancer in the last 5 years (except some low-risk skin or breast cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether robot-assisted surgery can be used safely and effectively for certain early-stage cervical cancers. It may help by using a precise surgical approach to remove the cancer while matching standard care for eligible patients.
This trial compares robotic surgery to open (traditional) surgery for women with early-stage cervix cancer. The goal is to see which approach is safer and works better for cancer control and recovery.
This study tests whether a less invasive type of hysterectomy (keyhole surgery) works well for women with very early-stage cervical cancer. It aims to find a safer, faster recovery option for low-risk tumors.
This study looks at two ways to remove the uterus and cervix for early-stage cervical cancer: minimally invasive surgery (like laparoscopic or robotic) versus open surgery (traditional large incision). It checks whether the less invasive approach works just as well in terms of survival and keeping the cancer from coming back.
This trial tests how safe a specific minimally invasive surgery tool (an endoscopic stapler) is for people with early-stage cervical cancer. If you qualify, you would get surgery to remove the cervix area using a minimally invasive approach and the study will track safety outcomes.
This Phase 3 trial studies how best to treat intermediate-risk cervical cancer using radical surgery, with or without additional radiation after surgery. It may help find which approach lowers the chance the cancer comes back for patients with certain tumor risk features.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.